10/31/14 WST 51.25 West Pharmaceutical Services $WST Hit a 52 week high of 51.63 Closing the day 10/31/14 at 51.25 +1.07 +2.13% With a day low of 50.67 and a total volume of 430,200.
WST Recent Posts: http://investorshangout.com/West-Pharmaceutic...WST-53126/
WST West Pharmaceutical Services Recent Headline News
West Pharmaceutical Services Larger Than S&P 500 Component Allegheny Technologies
TheOnlineInvestor.com - Thu Oct 30, 3:43PM CDT
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component West Pharmaceutical Services, Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Allegheny...
WST: 51.25 (+1.07)
West Pharmaceutical posts 3Q profit
Automated Insights - Thu Oct 30, 6:10AM CDT
LIONVILLE, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported net income of $31 million in its third quarter.
WST: 51.25 (+1.07)
West Announces Third Quarter 2014 Results
Marketwired - Thu Oct 30, 6:02AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2014 and updated its revenue and gross margin guidance for 2014 and its long-term financial objectives.
WST: 51.25 (+1.07)
West Pharmaceutical Services Shares Up 13.0% Since SmarTrend's Buy Recommendation (WST)
Comtex SmarTrend(R) - Wed Oct 29, 9:23AM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 2 months, West Pharmaceutical Services has returned 12.97% as of today's recent price of $47.98.
WST: 51.25 (+1.07)
West to Host Third Quarter 2014 Conference Call
Marketwired - Thu Oct 23, 7:01AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today that it will release third quarter 2014 financial results before the market opens on Thursday, October 30, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-280-4960 (U.S.) or 857-244-7317 (International). The passcode is 46283848.
WST: 51.25 (+1.07)
West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark
PR Newswire - Tue Oct 21, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the Vial2Bag® DC device from the United States Food and Drug Administration, and also the CE Mark for the European Union.
WST: 51.25 (+1.07)
Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Monday: GAIN, GOOD, WST
at The Street - Fri Oct 17, 9:03AM CDT
GAIN GOOD WST are going ex-dividend Monday, Monday, October 20, 2014
WST: 51.25 (+1.07), GOOD: 18.10 (+0.10), GAIN: 7.35 (+0.07)
West Pharmaceutical CEO to retire next year
AP - Wed Oct 15, 8:50AM CDT
NEW YORK (AP) — West Pharmaceutical Services Inc. said Wednesday that its longtime CEO Donald Morel plans to retire in May. The company, which makes syringes, medicine vials and other medical products, also narrowed its earnings outlook for the year.
WST: 51.25 (+1.07)
West Pharmaceutical Services Announces CEO Retirement and Succession Plan
PR Newswire - Wed Oct 15, 7:22AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative drug packaging and administration systems, said today that Donald E. Morel, Jr., Ph.D., Chairman of the Board and Chief Executive Officer, has announced his intention to retire at the Company's Annual Meeting in May 2015. The West Board of Directors has retained Russell Reynolds Associates, a leading executive search firm, to launch a comprehensive search to identify Dr. Morel's successor.
WST: 51.25 (+1.07)
Global Pharmaceutical Packaging Market Outlook 2019: Key Players in the $86 Billion Industry are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG
M2 - Mon Oct 13, 5:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cbs5dv/global) has announced the addition of the "Global Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019)" report to their offering. The pharmaceutical packaging market is expected to grow at a CAGR of 8.38% to reach $86.7 billion by the end of 2019 from the current estimates of $57.9 billion. Some of the major vendors are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG. Pharmaceutical industry is seeing an exponential growth. With changing lifestyle, more and more people are being diagnosed with various diseases. With increased spending on healthcare by government of different countries world over, pharmaceutical has become a multi-billion dollar industry. Pharmaceutical manufacturers must follow stringent requirements to protect consumer safety and environmental regulations. Increasing cost pressures on pharmaceutical manufacturers is forcing them to pass on this cost on to packaging companies which has become a driving force of pharmaceutical packaging market. The rise in self-medication and over the counter products is also contributing to growth of this industry. It is necessary for packaging companies to manufacture such packages which meet the objectives of keeping the product safe from environment and vice versa. Also there should be proper labelling of the products so that, it cannot be counterfeited and it should have a longer shelf life. Some of the pharmaceutical packaging products being used to meet above objectives are ampoule, vial, dropper bottle, labels and patient information booklet. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Insights 4. Technology Overview 5. Pharmaceutical Packaging Market by Primary Packaging Material 6. Pharmaceutical Packaging Market Segmentation by Type of Packaging 7. Pharmaceutical Packaging Market Segmentation by Region 8. Competitive Intelligence and Investment Analysis 9. Vendor Profiles 10. Future of Pharmaceutical Packaging Market Companies Mentioned - Amcor - Aptargroup - CCL Industries - Gerresheimer AG - Intrapac - Klockner Pentaplast - Meadwestvaco Corporation - Rexam Plc - Schott AG - West Pharmaceutical Services - Wihuri Group For more information visit http://www.researchandmarkets.com/research/cbs5dv/global
WST: 51.25 (+1.07)
Europe Pharmaceutical Packaging Market Report 2014
M2 - Thu Oct 09, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d9r9nd/europe) has announced the addition of the "Europe Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019)" report to their offering. The research driven pharmaceutical market with the intent of bringing new medicines to improve the quality of life around the world is a key asset to the European economy. The exports from this region in 2012 totalled to 305 thousand million. This region accounted for more than 26% of the world pharmaceutical sales. This growth in the pharmaceutical market has spurred the growth in the pharmaceutical packaging also. Packaging is the key part of the pharmaceutical market because it helps with keeping the drugs safe from contamination and damage. The CAGR is estimated to be more than 7% till 2019 of the pharmaceutical packaging market in this region. Some of the major vendors are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Insights 4. Technology Overview 5. Europe Pharmaceutical Packaging Market by Primary Packaging Material 6. Europe Pharmaceutical Packaging Market Segmentation by Type of Packaging 7. Europe Pharmaceutical Packaging Market Segmentation 8. Competitive Intelligence and Investment Analysis 9. Vendor Profiles 10. Future of Europe - Pharmaceutical Packaging Market Companies Mentioned - Amcor - Aptargroup - CCL Industries - Gerresheimer AG - Intrapac - KlocknerPentaplast - Meadwestvaco Corporation - Nypro - Rexam Plc - Schott AG - West Pharmaceutical Services - Wihuri Group For more information visit http://www.researchandmarkets.com/research/d9r9nd/europe
WST: 51.25 (+1.07)
West Names New President of Pharmaceutical Packaging Systems
PR Newswire - Tue Oct 07, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) has appointed Karen Flynn President of the company's Pharmaceutical Packaging Systems business. Pharmaceutical Packaging Systems is a global business unit within West, and is the company's largest, generating annual sales revenue of nearly $1 billion.
WST: 51.25 (+1.07)
West Pharmaceutical Services and HealthPrize Technologies Join Forces on Connected Health
PR Newswire - Mon Oct 06, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC today announced a strategic collaboration to integrate HealthPrize's Software-as-a-Service (SaaS) medication adherence and patient engagement platform with West's injectable drug delivery systems, to provide an end-to-end connected health solution to pharmaceutical companies and the patients they serve. The combined offering will provide electronically-connected drug delivery systems that track when patients take their medication, educate and engage patients to increase adherence and medical literacy, and reward them for compliance with their prescribed regimen.
WST: 51.25 (+1.07)
West to construct new pharmaceutical component manufacturing plant in Waterford, Ireland to meet customer demand
M2 - Fri Oct 03, 6:19AM CDT
Injectable drug company West Pharmaceutical Services (NYSE:WST) Thursday announced a new site in Waterford, Ireland under its global manufacturing expansion operations plan.
WST: 51.25 (+1.07)
West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland
PR Newswire - Thu Oct 02, 4:30AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today it plans to expand its global manufacturing operations to include a new site in Waterford, Ireland. The new facility will produce packaging components for insulin injector cartridges and other high-value packaging components, in order to meet growing demand from pharmaceutical and biotech customers. Once operational, this new site could bring approximately 150 new jobs to Waterford and is intended to grow to support additional jobs through future expansions.
WST: 51.25 (+1.07)
Global Pre-Filled Syringes Market 2014-2024: Becton Dickinson, Gerresheimer, MGlas AG, SCHOTT and Nuova Ompi Dominate the Market
M2 - Mon Sep 22, 3:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/48q7tm/prefilled) has announced the addition of the "Pre-Filled Syringes Market (2nd Edition), 2014 - 2024" report to their offering. Prefilled syringes are gaining strong acceptance in the market as drug delivery systems for injectable drugs. They have become a preferred device for parenteral administration of drugs, mainly used for treatment of chronic conditions requiring patients to self-administer medication several times a week. This report provides a comprehensive analysis of the state of prefilled syringes market. Starting with the basic introduction to prefilled syringes, their origin, components, and manufacturing material, this report talks about needlestick injuries and looks at the safety laws and legislations across major regional markets for injectable delivery. A key objective of the report is to enumerate various prefilled syringe systems available in the market, drugs available in these syringes and the corresponding market potential across different geographical regions. We have discussed various historical / likely future trends which have shaped / will shape the US, European, Japanese, Chinese and Rest of the World markets (such as India and Indonesia). We have also included a brief overview of biologics and biosimilars, one of the primary growth drivers of this market. Key Highlights - The global prefilled syringes market is likely to grow at a compounded annual growth rate (CAGR) of 11.3% between 2013 to 2024. By 2024, we expect the market to achieve sales of around 12.4 billion prefilled syringes. - Vaccines, diluent and flush syringes are likely to be some of the key growth areas. The emergence of biologics will be a major growth driver; growth in the long-term will be fuelled by pipeline drugs and the rising adoption in developing markets. - Increasing number of suppliers now provide ready to fill/ sterile prefilled syringes, which make up more than 80% of the prefilled syringes market. The integration of prefilled syringes with advanced delivery systems such as pen and autoinjectors will aid in gaining wider adoption. - Developed markets of the US and EU together accounted for 80% of the prefilled syringes market in 2013. With the increasing adoption in China and rest of the world markets, this domination is likely to decline; by 2024, we expect the share of US and EU markets to slip to 60%. - The market is highly consolidated and is currently dominated by key global players such as Becton Dickinson, Gerresheimer, MGlas AG, SCHOTT and Nuova Ompi. Other companies, which are relatively new entrants (e.g. West Pharmaceutical Services, Unilife and Vetter Pharma) are likely to foster more innovation. - Many regional players, especially in China, Japan and other Asian economies, have also recently surfaced to exploit the opportunity offered by large home consumer markets. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction To Prefilled Syringes 4. Growth Drivers 5. Products Available In Prefilled Syringes 6. Technological Development In Prefilled Syringes 7. Leading Global Prefilled Syringe Manufacturers 8. Regional Prefilled Syringe Manufacturers 9. Swot Analysis 10. Leading Regional Markets For Prefilled Syringe Systems, 2014 - 2024 11. Global Prefilled Syringes Market Forecast, 2014 - 2024 12. Interview Transcripts 13. Conclusion 14. Appendix 1: Tabulated Data 15. Appendix 2: List Of Companies And Organisations For more information visit http://www.researchandmarkets.com/research/48q7tm/prefilled
WST: 51.25 (+1.07)
Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade - 2014 Report for the $42 Billion Industry
M2 - Mon Sep 15, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmf95l/surgical) has announced the addition of Supplier Relations US, LLC's new report "Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade [2014 Q3 Edition]" to their offering. The Surgical Appliance and Supplies Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. The industry's revenue for the year 2013 was reported at $42.3 billion USD, with an estimated gross profit of 44.21%. Import was valued at $12.5 billion USD from 91 countries. The industry also exported $8.8 billion USD worth of merchandise to 199 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2013 was $46.0 billion USD. In this report, you will find industry data on the following major categories: - Executive Summary - Industry Income Statement - Industry Balance Sheet - Capital Expenditure - Industry Cost Analysis - Industry Pricing Analysis - Industry Foreign Trade - Industry Structure - Competitive Landscape Companies Mentioned - Baxter International Inc. - Becton, Dickinson & Company - Boston Scientific Corporation - Cardinal Health, Inc. - Cooper Companies Inc. - Covidien - Edwards Lifesciences Corporation - Hill-Rom - Intuitive Surgical, Inc. - Invacare Corporation - Johnson & Johnson - Kimberly-Clark Corporation - Kinetic Concepts, Inc. - Medtronic, Inc. - Mine Safety Appliances Company - Pall Corporation - Royal Philips Electronics - St. Jude Medical, Inc. - STERIS Corporation - Stryker Corporation - Synthes North America - Teleflex Incorporated - West Pharmaceutical Services, Inc. - Wright Medical Group, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/hmf95l/surgical Source: Supplier Relations US, LLC
ZMH: 111.24 (+1.96), WST: 51.25 (+1.07), BDX: 128.70 (+1.18), PHG: 27.94 (+0.46), MDT: 68.16 (+0.73), CAH: 78.48 (+0.29), KMB: 114.27 (+0.65), EW: 120.92 (+0.64), WMGIZ: 4.39 (-0.06), MSA: 57.47 (+1.91), COO: 163.90 (+0.24), BSX: 13.28 (+0.10), ISRG: 495.80 (+5.80), JNJ: 107.78 (+0.74), PLL: 91.42 (+0.50), IVC: 15.71 (+0.01), STE: 61.80 (+0.96), BAX: 70.14 (+0.08), STJ: 64.17 (-0.11), TFX: 114.12 (+1.25), SYK: 87.53 (+0.49)
Europe Pharmaceutical Packaging Market 2014-2019: Key vendors are Amcor, CCL Industries, Intrapac, Rexam Plc & Schott AG
M2 - Thu Sep 04, 9:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pnpqtf/europe) has announced the addition of the "Europe Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019)" report to their offering. Pharmaceutical industry is seeing an exponential growth. With changing lifestyle and more and more people being diagnosed with various diseases and increased spending on healthcare by government of different countries world over pharmaceutical has become a multi-billion dollar industry. Pharmaceutical manufacturers must follow stringent requirements to protect consumer safety and environmental regulations. Increasing cost pressures on pharmaceutical manufacturers is forcing them to pass on this cost on to packaging companies which has become one of the driving force of pharmaceutical packaging market. The rise in self-medication and over the counter products is also contributing to growth of this industry. It is necessary for packaging companies to manufacture such packages which meet the objectives of keeping the product safe from environment and vice versa. Also there should be proper labeling of the products so that, it cannot be counterfeited as well as maintain a longer shelf life. Some of the pharmaceutical packaging products being used to meet above objectives are ampoule, vial, dropper bottle, labels and patient information booklet. Some of the major vendors are - Amcor - CCL Industries - Intrapac - Rexam Plc - Schott AG Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Insights 4. Technology Overview 5. Europe Pharmaceutical Packaging Market by Primary Packaging Material 6. Europe Pharmaceutical Packaging Market Segmentation by Type of Packaging 7. Europe Pharmaceutical Packaging Market Segmentation 8. Competitive Intelligence and Investment Analysis 9. Vendor Profiles 10. Future of European Pharmaceutical Packaging Market Companies Mentioned - Amcor - Aptargroup - CCL Industries - Gerresheimer AG - Intrapac - KlocknerPentaplast - Meadwestvaco Corporation - Nypro - Rexam Plc - Schott AG - West Pharmaceutical Services - Wihuri Group For more information visit http://www.researchandmarkets.com/research/pnpqtf/europe
WST: 51.25 (+1.07)
West to Present at Upcoming Investor Conferences
Marketwire - Tue Sep 02, 3:10PM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in two upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences:
WST: 51.25 (+1.07)
West Pharmaceutical Services Earnings Hindsight: Up 3.1% in Last 18 Days (WST)
Comtex SmarTrend(R) - Mon Aug 18, 8:46AM CDT
When West Pharmaceutical Services (NYSE:WST) reported earnings 18 days ago on July 31st, 2014, analysts, on average, expected the company to report earnings of $0.47 on sales of $368.7 million. The company actually reported EPS of $0.52 on sales of $368.9 million, beating EPS estimates by $0.05 and matching revenue estimates. Since the company's report, shares of West Pharmaceutical Services have risen from $40.75 to $42.02, representing a gain of 3.1% in the past 18 days.
WST: 51.25 (+1.07)
WST Recent Posts: http://investorshangout.com/West-Pharmaceutic...WST-53126/
WST West Pharmaceutical Services Recent Headline News
West Pharmaceutical Services Larger Than S&P 500 Component Allegheny Technologies
TheOnlineInvestor.com - Thu Oct 30, 3:43PM CDT
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component West Pharmaceutical Services, Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Allegheny...
WST: 51.25 (+1.07)
West Pharmaceutical posts 3Q profit
Automated Insights - Thu Oct 30, 6:10AM CDT
LIONVILLE, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported net income of $31 million in its third quarter.
WST: 51.25 (+1.07)
West Announces Third Quarter 2014 Results
Marketwired - Thu Oct 30, 6:02AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2014 and updated its revenue and gross margin guidance for 2014 and its long-term financial objectives.
WST: 51.25 (+1.07)
West Pharmaceutical Services Shares Up 13.0% Since SmarTrend's Buy Recommendation (WST)
Comtex SmarTrend(R) - Wed Oct 29, 9:23AM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 2 months, West Pharmaceutical Services has returned 12.97% as of today's recent price of $47.98.
WST: 51.25 (+1.07)
West to Host Third Quarter 2014 Conference Call
Marketwired - Thu Oct 23, 7:01AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today that it will release third quarter 2014 financial results before the market opens on Thursday, October 30, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-280-4960 (U.S.) or 857-244-7317 (International). The passcode is 46283848.
WST: 51.25 (+1.07)
West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark
PR Newswire - Tue Oct 21, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the Vial2Bag® DC device from the United States Food and Drug Administration, and also the CE Mark for the European Union.
WST: 51.25 (+1.07)
Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Monday: GAIN, GOOD, WST
at The Street - Fri Oct 17, 9:03AM CDT
GAIN GOOD WST are going ex-dividend Monday, Monday, October 20, 2014
WST: 51.25 (+1.07), GOOD: 18.10 (+0.10), GAIN: 7.35 (+0.07)
West Pharmaceutical CEO to retire next year
AP - Wed Oct 15, 8:50AM CDT
NEW YORK (AP) — West Pharmaceutical Services Inc. said Wednesday that its longtime CEO Donald Morel plans to retire in May. The company, which makes syringes, medicine vials and other medical products, also narrowed its earnings outlook for the year.
WST: 51.25 (+1.07)
West Pharmaceutical Services Announces CEO Retirement and Succession Plan
PR Newswire - Wed Oct 15, 7:22AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative drug packaging and administration systems, said today that Donald E. Morel, Jr., Ph.D., Chairman of the Board and Chief Executive Officer, has announced his intention to retire at the Company's Annual Meeting in May 2015. The West Board of Directors has retained Russell Reynolds Associates, a leading executive search firm, to launch a comprehensive search to identify Dr. Morel's successor.
WST: 51.25 (+1.07)
Global Pharmaceutical Packaging Market Outlook 2019: Key Players in the $86 Billion Industry are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG
M2 - Mon Oct 13, 5:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cbs5dv/global) has announced the addition of the "Global Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019)" report to their offering. The pharmaceutical packaging market is expected to grow at a CAGR of 8.38% to reach $86.7 billion by the end of 2019 from the current estimates of $57.9 billion. Some of the major vendors are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG. Pharmaceutical industry is seeing an exponential growth. With changing lifestyle, more and more people are being diagnosed with various diseases. With increased spending on healthcare by government of different countries world over, pharmaceutical has become a multi-billion dollar industry. Pharmaceutical manufacturers must follow stringent requirements to protect consumer safety and environmental regulations. Increasing cost pressures on pharmaceutical manufacturers is forcing them to pass on this cost on to packaging companies which has become a driving force of pharmaceutical packaging market. The rise in self-medication and over the counter products is also contributing to growth of this industry. It is necessary for packaging companies to manufacture such packages which meet the objectives of keeping the product safe from environment and vice versa. Also there should be proper labelling of the products so that, it cannot be counterfeited and it should have a longer shelf life. Some of the pharmaceutical packaging products being used to meet above objectives are ampoule, vial, dropper bottle, labels and patient information booklet. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Insights 4. Technology Overview 5. Pharmaceutical Packaging Market by Primary Packaging Material 6. Pharmaceutical Packaging Market Segmentation by Type of Packaging 7. Pharmaceutical Packaging Market Segmentation by Region 8. Competitive Intelligence and Investment Analysis 9. Vendor Profiles 10. Future of Pharmaceutical Packaging Market Companies Mentioned - Amcor - Aptargroup - CCL Industries - Gerresheimer AG - Intrapac - Klockner Pentaplast - Meadwestvaco Corporation - Rexam Plc - Schott AG - West Pharmaceutical Services - Wihuri Group For more information visit http://www.researchandmarkets.com/research/cbs5dv/global
WST: 51.25 (+1.07)
Europe Pharmaceutical Packaging Market Report 2014
M2 - Thu Oct 09, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d9r9nd/europe) has announced the addition of the "Europe Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019)" report to their offering. The research driven pharmaceutical market with the intent of bringing new medicines to improve the quality of life around the world is a key asset to the European economy. The exports from this region in 2012 totalled to 305 thousand million. This region accounted for more than 26% of the world pharmaceutical sales. This growth in the pharmaceutical market has spurred the growth in the pharmaceutical packaging also. Packaging is the key part of the pharmaceutical market because it helps with keeping the drugs safe from contamination and damage. The CAGR is estimated to be more than 7% till 2019 of the pharmaceutical packaging market in this region. Some of the major vendors are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Insights 4. Technology Overview 5. Europe Pharmaceutical Packaging Market by Primary Packaging Material 6. Europe Pharmaceutical Packaging Market Segmentation by Type of Packaging 7. Europe Pharmaceutical Packaging Market Segmentation 8. Competitive Intelligence and Investment Analysis 9. Vendor Profiles 10. Future of Europe - Pharmaceutical Packaging Market Companies Mentioned - Amcor - Aptargroup - CCL Industries - Gerresheimer AG - Intrapac - KlocknerPentaplast - Meadwestvaco Corporation - Nypro - Rexam Plc - Schott AG - West Pharmaceutical Services - Wihuri Group For more information visit http://www.researchandmarkets.com/research/d9r9nd/europe
WST: 51.25 (+1.07)
West Names New President of Pharmaceutical Packaging Systems
PR Newswire - Tue Oct 07, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) has appointed Karen Flynn President of the company's Pharmaceutical Packaging Systems business. Pharmaceutical Packaging Systems is a global business unit within West, and is the company's largest, generating annual sales revenue of nearly $1 billion.
WST: 51.25 (+1.07)
West Pharmaceutical Services and HealthPrize Technologies Join Forces on Connected Health
PR Newswire - Mon Oct 06, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC today announced a strategic collaboration to integrate HealthPrize's Software-as-a-Service (SaaS) medication adherence and patient engagement platform with West's injectable drug delivery systems, to provide an end-to-end connected health solution to pharmaceutical companies and the patients they serve. The combined offering will provide electronically-connected drug delivery systems that track when patients take their medication, educate and engage patients to increase adherence and medical literacy, and reward them for compliance with their prescribed regimen.
WST: 51.25 (+1.07)
West to construct new pharmaceutical component manufacturing plant in Waterford, Ireland to meet customer demand
M2 - Fri Oct 03, 6:19AM CDT
Injectable drug company West Pharmaceutical Services (NYSE:WST) Thursday announced a new site in Waterford, Ireland under its global manufacturing expansion operations plan.
WST: 51.25 (+1.07)
West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland
PR Newswire - Thu Oct 02, 4:30AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today it plans to expand its global manufacturing operations to include a new site in Waterford, Ireland. The new facility will produce packaging components for insulin injector cartridges and other high-value packaging components, in order to meet growing demand from pharmaceutical and biotech customers. Once operational, this new site could bring approximately 150 new jobs to Waterford and is intended to grow to support additional jobs through future expansions.
WST: 51.25 (+1.07)
Global Pre-Filled Syringes Market 2014-2024: Becton Dickinson, Gerresheimer, MGlas AG, SCHOTT and Nuova Ompi Dominate the Market
M2 - Mon Sep 22, 3:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/48q7tm/prefilled) has announced the addition of the "Pre-Filled Syringes Market (2nd Edition), 2014 - 2024" report to their offering. Prefilled syringes are gaining strong acceptance in the market as drug delivery systems for injectable drugs. They have become a preferred device for parenteral administration of drugs, mainly used for treatment of chronic conditions requiring patients to self-administer medication several times a week. This report provides a comprehensive analysis of the state of prefilled syringes market. Starting with the basic introduction to prefilled syringes, their origin, components, and manufacturing material, this report talks about needlestick injuries and looks at the safety laws and legislations across major regional markets for injectable delivery. A key objective of the report is to enumerate various prefilled syringe systems available in the market, drugs available in these syringes and the corresponding market potential across different geographical regions. We have discussed various historical / likely future trends which have shaped / will shape the US, European, Japanese, Chinese and Rest of the World markets (such as India and Indonesia). We have also included a brief overview of biologics and biosimilars, one of the primary growth drivers of this market. Key Highlights - The global prefilled syringes market is likely to grow at a compounded annual growth rate (CAGR) of 11.3% between 2013 to 2024. By 2024, we expect the market to achieve sales of around 12.4 billion prefilled syringes. - Vaccines, diluent and flush syringes are likely to be some of the key growth areas. The emergence of biologics will be a major growth driver; growth in the long-term will be fuelled by pipeline drugs and the rising adoption in developing markets. - Increasing number of suppliers now provide ready to fill/ sterile prefilled syringes, which make up more than 80% of the prefilled syringes market. The integration of prefilled syringes with advanced delivery systems such as pen and autoinjectors will aid in gaining wider adoption. - Developed markets of the US and EU together accounted for 80% of the prefilled syringes market in 2013. With the increasing adoption in China and rest of the world markets, this domination is likely to decline; by 2024, we expect the share of US and EU markets to slip to 60%. - The market is highly consolidated and is currently dominated by key global players such as Becton Dickinson, Gerresheimer, MGlas AG, SCHOTT and Nuova Ompi. Other companies, which are relatively new entrants (e.g. West Pharmaceutical Services, Unilife and Vetter Pharma) are likely to foster more innovation. - Many regional players, especially in China, Japan and other Asian economies, have also recently surfaced to exploit the opportunity offered by large home consumer markets. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction To Prefilled Syringes 4. Growth Drivers 5. Products Available In Prefilled Syringes 6. Technological Development In Prefilled Syringes 7. Leading Global Prefilled Syringe Manufacturers 8. Regional Prefilled Syringe Manufacturers 9. Swot Analysis 10. Leading Regional Markets For Prefilled Syringe Systems, 2014 - 2024 11. Global Prefilled Syringes Market Forecast, 2014 - 2024 12. Interview Transcripts 13. Conclusion 14. Appendix 1: Tabulated Data 15. Appendix 2: List Of Companies And Organisations For more information visit http://www.researchandmarkets.com/research/48q7tm/prefilled
WST: 51.25 (+1.07)
Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade - 2014 Report for the $42 Billion Industry
M2 - Mon Sep 15, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmf95l/surgical) has announced the addition of Supplier Relations US, LLC's new report "Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade [2014 Q3 Edition]" to their offering. The Surgical Appliance and Supplies Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. The industry's revenue for the year 2013 was reported at $42.3 billion USD, with an estimated gross profit of 44.21%. Import was valued at $12.5 billion USD from 91 countries. The industry also exported $8.8 billion USD worth of merchandise to 199 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2013 was $46.0 billion USD. In this report, you will find industry data on the following major categories: - Executive Summary - Industry Income Statement - Industry Balance Sheet - Capital Expenditure - Industry Cost Analysis - Industry Pricing Analysis - Industry Foreign Trade - Industry Structure - Competitive Landscape Companies Mentioned - Baxter International Inc. - Becton, Dickinson & Company - Boston Scientific Corporation - Cardinal Health, Inc. - Cooper Companies Inc. - Covidien - Edwards Lifesciences Corporation - Hill-Rom - Intuitive Surgical, Inc. - Invacare Corporation - Johnson & Johnson - Kimberly-Clark Corporation - Kinetic Concepts, Inc. - Medtronic, Inc. - Mine Safety Appliances Company - Pall Corporation - Royal Philips Electronics - St. Jude Medical, Inc. - STERIS Corporation - Stryker Corporation - Synthes North America - Teleflex Incorporated - West Pharmaceutical Services, Inc. - Wright Medical Group, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/hmf95l/surgical Source: Supplier Relations US, LLC
ZMH: 111.24 (+1.96), WST: 51.25 (+1.07), BDX: 128.70 (+1.18), PHG: 27.94 (+0.46), MDT: 68.16 (+0.73), CAH: 78.48 (+0.29), KMB: 114.27 (+0.65), EW: 120.92 (+0.64), WMGIZ: 4.39 (-0.06), MSA: 57.47 (+1.91), COO: 163.90 (+0.24), BSX: 13.28 (+0.10), ISRG: 495.80 (+5.80), JNJ: 107.78 (+0.74), PLL: 91.42 (+0.50), IVC: 15.71 (+0.01), STE: 61.80 (+0.96), BAX: 70.14 (+0.08), STJ: 64.17 (-0.11), TFX: 114.12 (+1.25), SYK: 87.53 (+0.49)
Europe Pharmaceutical Packaging Market 2014-2019: Key vendors are Amcor, CCL Industries, Intrapac, Rexam Plc & Schott AG
M2 - Thu Sep 04, 9:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pnpqtf/europe) has announced the addition of the "Europe Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019)" report to their offering. Pharmaceutical industry is seeing an exponential growth. With changing lifestyle and more and more people being diagnosed with various diseases and increased spending on healthcare by government of different countries world over pharmaceutical has become a multi-billion dollar industry. Pharmaceutical manufacturers must follow stringent requirements to protect consumer safety and environmental regulations. Increasing cost pressures on pharmaceutical manufacturers is forcing them to pass on this cost on to packaging companies which has become one of the driving force of pharmaceutical packaging market. The rise in self-medication and over the counter products is also contributing to growth of this industry. It is necessary for packaging companies to manufacture such packages which meet the objectives of keeping the product safe from environment and vice versa. Also there should be proper labeling of the products so that, it cannot be counterfeited as well as maintain a longer shelf life. Some of the pharmaceutical packaging products being used to meet above objectives are ampoule, vial, dropper bottle, labels and patient information booklet. Some of the major vendors are - Amcor - CCL Industries - Intrapac - Rexam Plc - Schott AG Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Insights 4. Technology Overview 5. Europe Pharmaceutical Packaging Market by Primary Packaging Material 6. Europe Pharmaceutical Packaging Market Segmentation by Type of Packaging 7. Europe Pharmaceutical Packaging Market Segmentation 8. Competitive Intelligence and Investment Analysis 9. Vendor Profiles 10. Future of European Pharmaceutical Packaging Market Companies Mentioned - Amcor - Aptargroup - CCL Industries - Gerresheimer AG - Intrapac - KlocknerPentaplast - Meadwestvaco Corporation - Nypro - Rexam Plc - Schott AG - West Pharmaceutical Services - Wihuri Group For more information visit http://www.researchandmarkets.com/research/pnpqtf/europe
WST: 51.25 (+1.07)
West to Present at Upcoming Investor Conferences
Marketwire - Tue Sep 02, 3:10PM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in two upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences:
WST: 51.25 (+1.07)
West Pharmaceutical Services Earnings Hindsight: Up 3.1% in Last 18 Days (WST)
Comtex SmarTrend(R) - Mon Aug 18, 8:46AM CDT
When West Pharmaceutical Services (NYSE:WST) reported earnings 18 days ago on July 31st, 2014, analysts, on average, expected the company to report earnings of $0.47 on sales of $368.7 million. The company actually reported EPS of $0.52 on sales of $368.9 million, beating EPS estimates by $0.05 and matching revenue estimates. Since the company's report, shares of West Pharmaceutical Services have risen from $40.75 to $42.02, representing a gain of 3.1% in the past 18 days.
WST: 51.25 (+1.07)
